iShares Genomics Immunology and Healthcare ETF Rating $23.30 +0.18 (+0.78%) (As of 11/21/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.77Holdings in IDNA have an aggregate rating of Moderate Buy based on 424 analyst ratings issued in the past year covering 36 companies (70.7% of the portfolio).IDNA Aggregate Price Target$23.30High Prediction$23.30Average Prediction$23.30Low Prediction$23.30Holdings in IDNA have an aggregate price target of $23.30 and a range of $23.30 to $23.30 covering 36 companies (70.7% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 36 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.61%GILDGilead Sciences$89.84+1.4%4.6603 of 5 stars2.65$95.41 6.2%26Analyst UpgradePositive News5.20%EXELExelixis$34.83+0.5%4.7945 of 5 stars2.65$31.44 -9.7%20Insider Trade4.70%RVMDRevolution Medicines$56.78-0.5%2.7998 of 5 stars3.08$61.00 7.4%124.49%INCYIncyte$70.45-0.8%3.9183 of 5 stars2.38$77.16 9.5%21Analyst Forecast4.49%BNTXBioNTech$108.20+5.9%3.5056 of 5 stars2.81$138.79 28.3%16Analyst ForecastAnalyst Revision4.34%SRPTSarepta Therapeutics$110.50-0.3%4.9426 of 5 stars3.00$181.33 64.1%22Analyst Downgrade3.85%ACLXArcellx$87.222.9273 of 5 stars3.07$103.08 18.2%14Short Interest ↓3.80%REGNRegeneron Pharmaceuticals$745.48+0.3%4.8105 of 5 stars2.78$1,099.55 47.5%23Positive News3.25%MRKMerck & Co., Inc.$100.41+3.0%4.9964 of 5 stars2.68$130.86 30.3%19Dividend IncreaseNews CoveragePositive News2.72%IOVAIovance Biotherapeutics$8.24+1.2%4.0607 of 5 stars2.89$22.33 171.0%9Options Volume2.58%TWSTTwist Bioscience$41.89+1.9%3.8001 of 5 stars2.67$51.78 23.6%9Analyst ForecastAnalyst RevisionNews Coverage2.32%GERNGeron$4.02+0.8%3.5359 of 5 stars3.00$7.05 75.4%112.24%LGNDLigand Pharmaceuticals$116.86+4.8%4.9361 of 5 stars3.00$144.83 23.9%62.20%SWTXSpringWorks Therapeutics$36.30-3.0%2.0452 of 5 stars3.00$67.00 84.6%7Analyst Forecast1.89%BEAMBeam Therapeutics$23.52-4.0%2.9756 of 5 stars2.75$44.91 90.9%121.80%BCRXBioCryst Pharmaceuticals$7.51+2.9%4.171 of 5 stars2.80$15.60 107.9%5Short Interest ↓1.70%NRIXNurix Therapeutics$22.37-1.2%2.7301 of 5 stars2.93$29.40 31.4%151.59%DVAXDynavax Technologies$12.37+1.6%4.7225 of 5 stars2.67$22.00 77.9%31.48%NVAXNovavax$8.09+0.4%3.6975 of 5 stars2.33$17.83 120.4%6Analyst Revision1.43%MRNAModerna$38.40+4.0%4.574 of 5 stars2.18$84.00 118.7%22Analyst UpgradeAnalyst Revision1.29%BPMCBlueprint Medicines$96.66+2.0%2.7258 of 5 stars2.71$122.11 26.3%21Analyst ForecastAnalyst Revision0.98%CRSPCRISPR Therapeutics$46.25-2.1%1.7973 of 5 stars2.37$74.94 62.0%190.94%IBRXImmunityBio$5.10+4.5%0.5357 of 5 stars3.00$4.75 -6.8%20.89%RCUSArcus Biosciences$14.30-2.2%2.7633 of 5 stars3.00$34.00 137.8%90.76%VIRVir Biotechnology$6.95+3.1%3.0347 of 5 stars2.60$36.40 423.7%5Analyst Forecast0.64%ABCLAbCellera Biologics$2.72+1.9%3.0263 of 5 stars2.67$8.67 218.6%3Positive News0.53%ARCTArcturus Therapeutics$17.06+5.5%2.2213 of 5 stars3.13$71.40 318.5%80.41%OABIOmniAb$3.85-1.3%1.6744 of 5 stars3.00$9.00 133.8%40.40%FDMT4D Molecular Therapeutics$7.99-5.0%3.0372 of 5 stars2.70$42.13 427.2%10Analyst ForecastAnalyst RevisionNews Coverage0.39%NTLAIntellia Therapeutics$13.86+5.6%4.5521 of 5 stars2.72$54.94 296.3%18Analyst ForecastAnalyst Revision0.36%QUREuniQure$5.85+2.5%2.9343 of 5 stars2.67$17.00 190.8%6News CoverageNegative News0.33%DNAGinkgo Bioworks$6.59+3.5%1.1513 of 5 stars1.60$4.58 -30.5%5Short Interest ↓0.32%XNCRXencor$24.10+1.6%3.5832 of 5 stars3.00$35.75 48.3%80.30%EDITEditas Medicine$2.37-1.7%4.7031 of 5 stars2.54$9.08 283.3%13Short Interest ↓0.29%CVACCureVac$2.56+2.8%4.5264 of 5 stars2.25$10.00 290.6%40.23%MGNXMacroGenics$3.19-2.7%3.8654 of 5 stars2.36$7.63 138.7%11 This page (NYSEARCA:IDNA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts